Deadly Allergy

Investigating causes and cures of anaphylaxis

  • News
  • Science
  • Resources
    • Airborne / Contact Allergy
    • They know …..
    • Iatrogenesis
  • History
  • Treatments
  • PENTA Project
  • Contact Us

Category Archives: Uncategorized

Vaccines contain food proteins

2nd February, 2020 · admin

posted with permission

Vinu Arumugham responds to the authors of Food allergen component proteins are not detected in early-childhood vaccines published in The Journal of Allergy and Clinical Immunology: In Practice

Date: Wed, 30 Jan 2019 01:06:58 -0800
From: vinu arumugham
To: tap2z@virginia.edu , js3ch@virginia.edu

All,

This is regarding your study – Food allergen component proteins are not detected in early-childhood vaccines. (1)⁠

Thank you for performing this study. I recall requesting Dr.Platts-Mills that the Prevnar 13 vaccine be tested for peanut protein. I am happy to see that was performed as well. While the data is important, there are many serious issues with your conclusions and interpretation.

Background

Fact 1: Vaccines contain food proteins. There are no controls for labeling or limiting cross contamination among vaccines and other medical products. Vaccine and excipient makers use numerous food products during manufacture and could also be using shared equipment which can be a source of contamination. The US National Academy of Medicine has concluded and warned that vaccines include numerous food proteins including peanut, sesame, soy, milk, gelatin, egg, beef, fish etc. (2)⁠

“Allergens in Vaccines, Medications, and Dietary Supplements

Physicians and patients with food allergy must consider potential food allergen exposures in vaccines, medications, and dietary supplement prod- ucts (e.g., vitamins, probiotics), which are not regulated by labelling laws. Also, excipients (i.e., substances added to medications to improve various characteristics) may be food or derived from foods (Kelso, 2014). These include milk proteins; soy derivatives; oils from sesame, peanut, fish or soy; and beef or fish gelatin. The medications involved include vaccines; anesthetics; and oral, topical, and injected medications. With perhaps the exception of gelatin, reactions appear to be rare overall, likely because little residual protein is included in the final preparation of these items. The specific risk for each medication is not known.

Vaccines also may contain food allergens, such as egg protein or gelatin.”

Many food proteins in vaccines have both been declared and measured. For example, milk proteins (3)⁠, gelatin (4,5)⁠ and egg proteins (6)⁠.

Fact 2: Food proteins in vaccines cause the development of food allergies. The US Institute of Medicine studied the entire vaccine literature from 1950 to 2011 to come to this conclusion. (7)⁠

p. 65 (pdf p. 94):

“Adverse events on our list thought to be due to IgE-mediated hypersensitivity reactions

Antigens in the vaccines that the committee is charged with reviewing do not typically elicit an immediate hypersensitivity reaction (e.g., hepatitis B surface antigen, toxoids, gelatin, ovalbumin, casamino acids). However, as will be discussed in subsequent chapters, the above-mentioned antigens do occasionally induce IgE-mediated sensitization in some individuals and subsequent hypersensitivity reactions, including anaphylaxis.”

Here are examples of vaccine and injection induced IgE mediated sensitization that the IOM used to come to its conclusion.

Egg protein containing vaccines induce IgE mediated sensitization to egg proteins. (8,9)⁠

Similarly, gelatin (4,5)⁠, influenza viral proteins (10–13)⁠, toxoids (14–16)⁠, Hepatitis B virus surface antigen (17)⁠.

Repeated bee stings cause IgE mediated allergy to bee venom. (18)⁠

Bovine serum albumin (BSA) containing vaccines caused IgE mediated sensitization to BSA in horses. (19)⁠

Similar results in dogs. (20–22)⁠

Your team’s own study (23,24)⁠ confirmed the above. So food protein containing vaccines causing the development of food allergies is NOT a hypothesis, it is a fact. (25,26)⁠

When designing a new product, we first build only a few prototypes. If the prototypes fail, you know you have a major design problem. Your team’s WAO study with n=2 was exactly like that. A two out of two failure (allergy boost), is a very valuable outcome showing fundamental design problems with the vaccines.

Your statements

You make these assertions below but did not provide a reason or cite any references.

“The likelihood is low that early-childhood vaccines would contain food allergens.”

There are no specifications or controls. (25)⁠ Vaccine and excipient makers use numerous food products during production. So what is the basis for this statement?

“These findings do not support the concept that early-childhood vaccines or VitK injections contain allergy-causing food allergens.”

It is impossible to make such a sweeping claim unless you are able to detect the presence of even one molecule of the allergen.

“Without evidence of significant food allergen within the vaccines, the aforementioned hypothesis of vaccine-associated sensitization is unsupported.”

“Although the ELISA detection limits are quite low, the amount of allergen required to cause sensitization is poorly understood.”

As you admit, the amount of allergen required for sensitization is unknown. So how do you know how much is “significant food allergen”? With your limited detection capability, it is therefore impossible to jump to the conclusion that “the aforementioned hypothesis of vaccine-associated sensitization is unsupported.”, especially after you yourself have demonstrated that these food protein containing vaccines indeed boosted food allergies, exactly as expected from basic immunology. (23)⁠

“Theoretically, it could be argued that the ELISA limits of detection may not be low enough, though this seems unlikely because these are the most sensitive assays available with detection limits in the nanogram range and have been used before to detect these antigens.”

What has the “most sensitive assays available” got to do with the amount of allergen required for human sensitization?

“What is reassuring is that children with peanut, cow’s milk, and egg allergy continue to receive these vaccines in the first year of life without having allergic reactions.”

That only allows you to make conclusions about the elicitation dose, not the sensitization dose.

Conclusion

Sensitization dose is less than elicitation dose (25)⁠. Kattan et al. showed that 8-18ng/ml of casein was enough to elicit anaphylaxis. That is proof that sensitization dose is much less than 8-18ng/ml for casein.

Also Norowitz et al. (12)⁠ found that ELISA was not as sensitive as “dot blot” technology for some of their work.

It looks at least for now, that the most sensitive allergen detector available is the human immune system. Your team’s own study (23)⁠ demonstrated that vaccines do indeed boost food allergies as would be expected with food allergen contaminated vaccines. It is rather strange that you have ignored that most important finding, based on this limited measurement data, while the dose needed for human sensitization (especially with the antigen adsorbed on a Th2 biased adjuvant), is still unknown.

Further, your measurement sample size is extremely small. As I describe (25)⁠, 7.4 mcg/ml of ovalbumin was detected in the influenza vaccine in 1967. But as much as 38 mcg/ml of ovalbumin was detected as recently as 2008. There is a huge variation among vendors, between years from the same vendor and among lots.

Unlike your WAO study situation, here you are trying to prove the safety of vaccines. Continuing the prototype example, when we go into volume production we have to build large number of products and test them to ensure quality. Likewise, to prove vaccine safety with regards to food protein contamination, such a small sample size is obviously inadequate to assess the quality of tens of millions of vaccine doses. Arepanrix and Pandemrix vaccines manufactured by the same company – GSK, in two different countries, had different levels of H1N1 nucleoproteins. Pandemrix induced narcolepsy (27)⁠ in thousands and Arepanrix did not. That’s another example of widely varying amounts of non-target proteins in vaccines and the callous disregard among vaccine makers for the devastating safety problems caused by off-target immune responses. (28,29)⁠

I hope you will publish a correction addressing these serious issues because your conclusions are very misleading. Until you can establish food allergen sensitization amounts (taking into account the effects of aluminum adjuvant, numerous repeated vaccines, an atopic population that lacks helminth infections, c-section birth and antibiotic related sub optimal gut microbiome, etc.) and vaccine manufacturers put in place statistical quality controls that can detect and prevent such sensitization amounts, we can NEVER make the claim that vaccines do not cause sensitization. Alternately, vaccine production should not be based on food proteins at all. (3,5)⁠

And, by the way, food proteins are not the only problem, aeroallergen contamination of vaccines results in asthma and numerous other diseases. (30)⁠

Thanks,

Vinu

References

1. Hoyt AEW, Chapman MD, King EM, Platts-Mills TAE, Steinke JW. Food allergen component proteins are not detected in early-childhood vaccines. J allergy Clin Immunol Pract. United States; 2018 Mar;6(2):677–9.

2. National Academies of Sciences and Medicine E. Finding a Path to Safety in Food Allergy: Assessment of the Global Burden, Causes, Prevention, Management, and Public Policy. Stallings VA, Oria MP, editors. Washington, DC: The National Academies Press; 2017.

3. Kattan JD, Cox AL, Nowak-Wegrzyn A, Gimenez G, Bardina L, Sampson HA, et al. Allergic reactions to diphtheria, tetanus, and acellular pertussis vaccines among children with milk allergy. J Allergy Clin Immunol. 2011;Conference(var.pagings):AB238.

4. Nakayama T, Aizawa C, Kuno-Sakai H. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol. Elsevier; 1999 Jan 9;103(2):321–5.

5. Kuno-Sakai H, Kimura M. Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy. Biologicals. 2003 Dec;31(4):245–9.

6. Goldis M, Bardina L, Lin J, Sampson HA. Evaluation of Egg Protein Contamination in Influenza Vaccines. J Allergy Clin Immunol. Elsevier; 2016 Jan 9;125(2):AB129.

7. Stratton K. Adverse Effects of Vaccines: Evidence and Causality. Stratton K, Ford A, Rusch E, Clayton EW, editors. Washington, DC: The National Academies Press; 2012.

8. Yamane N, Uemura H. Serological examination of IgE- and IgG-specific antibodies to egg protein during influenza virus immunization. Epidemiol Infect. Cambridge University Press; 1988 Apr;100(2):291–9.

9. Ratner B, Untracht S, Hertzmark F. Allergy to Viral and Rickettsial Vaccines. N Engl J Med. 1952 Apr 3;246(14):533–6.

10. Nagao M, Fujisawa T, Ihara T, Kino Y. Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine-associated anaphylaxis. J Allergy Clin Immunol. United States; 2016 Mar;137(3):861–7.

11. Nakayama T, Kumagai T, Nishimura N, Ozaki T, Okafuji T, Suzuki E, et al. Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine. Vaccine. 2015 Nov 9;33(45):6099–105.

12. Smith-Norowitz TA, Wong D, Kusonruksa M, Norowitz KB, Joks R, Durkin HG, et al. Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine. Int J Med Sci. Ivyspring International Publisher; 2011 Mar 18;8(3):239–44.

13. Davidsson A, Eriksson JC, Rudblad S, Brokstad KA. Influenza Specific Serum IgE is Present in Non-Allergic Subjects. Scand J Immunol. 2005 Dec;62(6):560–1.

14. Markt A, Björkstén B, Granström M. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine. 1995;13(7):669–73.

15. Hedenskog S, Bjorksten B, Blennow M, Granstrom G, Granstrom M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol. 1989;89(2-3):156–61.

16. Edelman K, Malmstrom K, He Q, Savolainen J, Terho EO, Mertsola J. Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization. Eur J Pediatr. Germany; 1999 Dec;158(12):989–94.

17. Smith-Norowitz TA, Tam E, Norowitz KB, Chotikanatis K, Weaver D, Durkin HG, et al. IgE anti Hepatitis B virus surface antigen antibodies detected in serum from inner city asthmatic and non asthmatic children. Hum Immunol. United States; 2014 Apr;75(4):378–82.

18. Eich-Wanger C, Muller UR. Bee sting allergy in beekeepers. Clin Exp Allergy. 1998;28(10):1292–8.

19. Gershwin LJ, Netherwood KA, Norris MS, Behrens NE, Shao MX. Equine IgE responses to non-viral vaccine components. Vaccine. Netherlands; 2012 Dec;30(52):7615–20.

20. Ohmori K, Masuda K, Maeda S, Kaburagi Y, Kurata K, Ohno K, et al. IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination. Vet Immunol Immunopathol. 2005 Apr;104(3-4):249–56.

21. Tater KC, Jackson HA, Paps J, Hammerberg B. Effects of routine prophylactic vaccination or administration of aluminum adjuvant alone on allergen-specific serum IgE and IgG responses in allergic dogs. Am J Vet Res. 2005 Sep;66(9):1572–7.

22. HogenEsch H, Dunham AD, Scott-Moncrieff C, Glickman LT, DeBoer DJ. Effect of vaccination on serum concentrations of total and antigen-specific immunoglobulin E in dogs. Am J Vet Res. American Veterinary Medical Association; 2002 Apr 1;63(4):611–6.

23. Alice Hoyt, Peter Heymann, Alexander Schuyler, Scott Commins TAEP-M. Changes in IgE Levels Following One-Year Immunizations in Two Children with Food Allergy [Internet]. 2015. Available from: https://wao.confex.com/wao/2015symp/webprogram/Paper9336.html

24. Arumugham V. Vaccines and the development of food allergies: the latest evidence [Internet]. BMJ. 2016. Available from: https://www.bmj.com/content/355/bmj.i5225/rr-0

25. Arumugham V. Evidence that Food Proteins in Vaccines Cause the Development of Food Allergies and Its Implications for Vaccine Policy. J Dev Drugs. 2015;4(137):2.

26. Arumugham V. Professional Misconduct by NAM Committee on Food Allergy [Internet]. 2016. Available from: https://www.zenodo.org/record/1034559

27. Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 (ABSTRACT ONLY). Sci Transl Med. 2015;7(294):294ra105–294ra105.

28. Arumugham V. Pandemrix and Arepanrix vaccine safety analysis and scrutiny fell short [Internet]. The BMJ. 2018. Available from: https://www.bmj.com/content/363/bmj.k4152/rr-14

29. Arumugham V. Pharmacovigilance is no substitute for good vaccine design [Internet]. The BMJ. 2018. Available from: https://www.bmj.com/content/362/bmj.k3948/rr-11

30. Arumugham V. Aeroallergen contamination of multi-dose and reconstituted vaccine vials cause the development of asthma, gastrointestinal diseases and proves vaccine makers and vaccine safety regulators are incompetent [Internet]. 2019 [cited 2019 Jan 22]. Available from: https://doi.org/10.5281/zenodo.2544037

 

Posted in Uncategorized | Tags: IgE, Vinu Arumugham |

Influenza allergy?

7th April, 2018 · admin

Vinu Arumugham makes a case in a British Medical Journal Rapid Response titled Influenza vaccines seem to be modifying influenza into a dangerous dengue-like disease that flu shots are causing allergy to influenza virus.

“Last year’s influenza vaccine also contained the same H3N2 strain as this year’s vaccine (A/Hong Kong/4801/2014 (H3N2)-like virus). Many people would have developed long term IgE mediated sensitization to the H3N2 viral proteins due to last year’s vaccine [1–4]⁠. Those who received the Flublok vaccine can be expected to have an even stronger IgE response due to its 3X viral protein content [5,4]⁠. This year’s vaccine H3N2 proteins would have been neutralized by these IgE antibodies. Thus resulting in the observed low vaccine efficacy. [6⁠]

When a person making anti-H3N2 IgE is infected with H3N2, one can expect the course of the flu to be significantly worse. So the “cytokine storm” being observed in severe cases is likely to be an infection concurrent with an allergic reaction. Death is caused by anaphylactic shock but due to the presence of an infection, it is wrongly classified as septic shock.

In the case of food allergy for example, the allergen exposure can be large enough to cause an immediate hypersensitivity reaction and anaphylactic shock within minutes/hours. In the case of influenza allergy, it may take a day or two for the virus to replicate and produce enough viral exposure for anaphylaxis. So the anaphylaxis unfolds over a couple of days. …..

The route of exposure for natural influenza infection is the respiratory tract, not subcutaneous (SC) or intramuscular (IM) injection. Influenza vaccines artificially changed the route of initial viral protein exposure to SC or IM injection thus making it similar to the route of exposure for dengue. The result is an IgE response to influenza proteins, similar to the response for dengue. It should therefore not come as a surprise that we are modifying the course of influenza infection such that it is acquiring characteristics of a dengue infection (hives and shock).

As a result, allergy medications such as antihistamines and anaphylaxis treatments may have to be considered to avoid or treat this man-made influenza shock syndrome.”

To read the full article including references click here.

 

 

 

Posted in Uncategorized | Tags: allergy, dengue, flu, IgE, influenza, Vinu Arumugham |

What about peanut oil in vaccines?

29th March, 2018 · admin

There is no direct evidence to our knowledge that peanut oil is an ingredient in current vaccinations.

The Epidemic of Allergy in Children Launched in the Late 1980s and Early 1990s – Heather Fraser

“Using the theory of food oils in the vaccines to explain the sudden nature of epidemic allergy does nothing to forward the conversation. We did not suddenly put food oils, bee venom, latex, dust, pollens, etc. in the vaccines. … There is ample evidence in the medical literature on the role of vaccination, the toxicity of vaccines and aluminum adjuvants in creating atopy that one does not need to speculate. Allergists already know.”

More details here:

Levi Quackenboss re: No Evidence of Peanut Oil In Vaccines

From Vaccine Ingredients Calculator (VaxCalc)

Is there peanut oil in vaccines?

We don’t know for sure whether or not peanut oil is now or ever has been in any vaccine.

“Peanut oil is not referenced in any of the FDA-approved vaccine package inserts for the vaccines currently in the VaxCalc database. … Another reason its not possible to say with confidence that peanut oil is not and never has been in a US licensed vaccine is that some ingredients are trade secrets and kept confidential.”

Vinu Arumugham #MAHA’s Substack post, SkepticalRaptor is wrong about peanut oil in vaccines. Vaccines are contaminated with numerous food proteins including peanut, per National Academy of Medicine thus causing the food allergy epidemic. – Corrupted FDA, HHS, US government are lawless entities that maim and kill, quotes a National Academy of Medicine 2017 report showing that vaccines contain “oils from sesame, peanut, fish or soy ….”

From The Vaccine Reaction

Merck’s Peanut Oil Adjuvant

“On September 19, 1964, an article titled “Peanut Oil Used In A New Vaccine” appeared in The New York Times.1 It was written by Stacey V. Jones. The piece noted that an influenza vaccine, which had just recently been patented by Merck & Co., Inc., carried a key ingredient known as Adjuvant 65, which contained peanut oil. The adjuvant, aimed at slowly releasing antigens to “stimulate the creation of antibodies,” was described as “an emulsion of refined peanut oil in water to which are added an emulsifier and a stabilizer.”1 … In her book The Peanut Allergy Epidemic: What’s Causing It and How to Stop It, Heather Fraser notes that Merck ultimately decided not to “pursue” Adjuvant 65 for use in vaccines licensed for use in the United States.”

PEANUT OIL USED IN A NEW VACCINE; Product Patented for Merck Said to Extend Immunity – September 19, 1964 – The New York Times

Response to influenza vaccine in adjuvant 65-4 – “A comparison was made of the antibody response and subjective reactions to zonally-purified influenza vaccine in aqueous suspension and in peanut oil adjuvant 65-4.”

Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine. – April 1985 – “Tissue damage caused by six different adjuvants incorporated in a Haemophilus pleuropneumoniae vaccine was compared in swine. The adjuvants compared were four mineral oil compounds, one peanut oil compound and aluminum hydroxide. Inoculations were given in the neck, quadriceps and semitendinosus muscles.”

For other vaccine ingredients, including aluminum adjuvants, implicated in the peanut allergy epidemic, please see the Science section.

Peanut allergy: sensitization by peanut oil–containing local therapeutics seems unlikely (2004) Journal of Allergy and Clinical Immunology – “We recognize the limitations of the animal model used and the fact that peanut is a more potent allergen compared with ovalbumin. Nevertheless, we believe that our results cast doubt on the proposition that pharmaceutical products containing refined peanut oil play a role in sensitization to peanut.”

 

Posted in Uncategorized | Tags: adjuvant, food allergy, peanut allergy, peanut oil |

Deadly food allergies and organ donation

16th November, 2016 · admin

2024 – Another tragic peanut anaphylaxis death ….  Hannah Glass kept alive after a deadly anaphylactic reaction so that her organs could be donated.

NY Post story here:  19-year-old Wis. college student with peanut allergy dies after eating gluten-free brownie: ‘She was completely unresponsive’

GiveSendGo fundraiser Remembering Hannah Glass


Via e-mail to ehoskins.mpp@liberal.ola.org

July 17, 2016

Dr. Eric Hoskins
Minister of Health and Long-Term Care
10th Floor, Hepburn Block
80 Grosvenor Street
Toronto, Ontario M7A 2C4

Persons with anaphylaxis encouraged to become organ donors at Service Ontario

Dear Dr. Hoskins,

My son, upon returning from a Service Ontario office regarding his OHIP coverage, showed me a form showing “I have agreed to donate any organ or tissue needed for transplant, or for medical research if they cannot be used for transplant.” I would not have thought twice about this had it not been for the fact that my son has life threatening food allergies. I won’t list all of the medical journal articles showing the dangers of anaphylactic donors causing anaphylaxis in
transplant recipients but here are a few:

Transfer of peanut allergy from the donor to a lung transplant recipient – “This case emphasizes the importance of considering donor allergy transfer when caring for all solid-organ transplant recipients in order to avoid a life-threatening event.”

A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation

Transfer of Symptomatic Peanut Allergy to the Recipient of a Combined Liver-And-Kidney Transplant

New developments in transplant-acquired allergies

As you can see from the above cases, for patients to have fully informed consent regarding their transplant, they should be advised if the donor does have life threatening allergies. The Sick Kids Foundation is reporting that there are 300,000 [update 2024, now 500,000] children in Canada with anaphylaxis. As far as I know numbers of adults (including my son) are unknown.

My son (now 22) is one of the first wave of children who received the 5 in 1 combination vaccinations or 5 doses concurrently that included Haemophilus Influenza type B (conjugate) as an infant. He is anaphylactic to numerous foods including peanuts, nuts, eggs, milk, sesame and has reacted severely to latex in the past after orthodontic treatment. Please see my website www.deadlyallergy.com/science to view the medical journal links between vaccination and developing anaphylaxis to foods. Are the 300,000 children [update 2024, now 500,000] in this country with anaphylaxis on any government’s radar? If not, they should be.

I look forward to your reply – What is the Ontario government going to do to protect transplant recipients from developing life threatening allergies after transplantation from an anaphylactic donor?

Sincerely,
Rita Hoffman

c.c. Dr. Jane Philpott, Minister of Health, Canada
Dr. Richard Schabas
Todd Smith, MPP

 

Subject: Requests for organ donation from persons who are anaphylaxis by Service Ontario – MECS #:16-008164-368
Date: Fri, 7 Oct 2016 13:21:11 -0400
From: BGTD.OPIC <BGTD.OPIC@hc-sc.gc.ca>
To: RH

Dear Ms. Hoffman:

Thank you for your correspondence of July 17, 2016, concerning the safety of organs for transplantation from donors with anaphylaxis.

Canada has one of the safest organ transplantation systems in the world thanks to its comprehensive regulatory oversight of the screening and testing of donors. The Safety of Human Cells, Tissues, and Organs for Transplantation Regulations address the safety in the processing and handling of cells, tissues, and organs thereby resulting in the improved protection of the health and safety of Canadian transplant recipients.  

You will be pleased to know that under the Regulations, there is a requirement to screen organ and stem cell donors for any allergies. If their donor’s history of allergies is considered clinically significant, for example, information on the presence of a life-threatening allergy, this information must then be communicated to the transplant program. The physician would then alert the recipient to avoid the allergen(s) in question or seek appropriate testing.

I hope this information allays the concerns you expressed for the well-being of potential transplant recipients. If you have any other questions regarding the safety of organs for transplantation, please do not hesitate to contact Health Canada officials at BGTD.OPIC@hc-sc.gc.ca.

Again, thank you for writing.

Office of Policy and International Collaboration  | Bureau de la politique et de la collaboration internationale
Biologics and Genetic Therapies Directorate   |  Direction des produits biologiques et des thérapies génétiques

Health Products and Food Branch  |  Direction générale des produits de santé et des aliments
Health Canada  |  Santé Canada
Tunney’s Pasture | Pré Tunney, Ottawa K1A 0T6
Mail stop  | Localisateur: 0601A
bgtd.opic@hc-sc.gc.ca | dpbtg.bpci@hc-sc.gc.ca

Posted in Uncategorized |

Search This Site

Pages

  • News
  • Science
  • Resources
    • Airborne / Contact Allergy
    • They know …..
    • Iatrogenesis
  • History
  • Treatments
  • PENTA Project
  • Contact Us

Recent Posts

  • COVID-19 Vaccine
  • CBC Ignores Vaccine Science
  • Vaccines contain food proteins
  • Influenza allergy?
  • What about peanut oil in vaccines?
  • PENTA Vaccine Letter
  • Deadly food allergies and organ donation
  • PENTA Cover-Up at CBC
  • Vaccines cause the development of food allergies: the latest evidence

Twitter

Follow @vaccinerisk

Pages

  • News
  • Science
  • Resources
    • Airborne / Contact Allergy
    • They know …..
    • Iatrogenesis
  • History
  • Treatments
  • PENTA Project
  • Contact Us

Archives

  • December 2020
  • February 2020
  • April 2018
  • March 2018
  • December 2016
  • November 2016
  • October 2016
  • July 2016

Categories

  • News (2)
  • PENTA Project (2)
  • Resources (1)
  • Uncategorized (4)

WordPress

  • Log in
  • WordPress
© A WordPress Site
  • News
  • Science
  • Resources
  • History
  • Treatments
  • PENTA Project
  • Contact Us